Pompano Beach, FL -- (SBWIRE) -- 02/20/2013 -- Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-
MediciNova, Inc. (NASDAQ:MNOV) added 14.59% and is trading at $2.12. MediciNova, Inc. is a development-stage biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs with a focus on the United States market.
Can MNOV Continue To Move Higher? Find Out Here
Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) is higher 21.09% and is trading at $6.66. Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on commercializing products for the hospital, respiratory and related specialty markets. The Company’s promoted products include CUROSURF, ZYFLO CR, FACTIVE and SPECTRACEF.
How Should Investors Trade CRTX Now? Find Out Here
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) added 8.52% and is trading at $4.84. Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors and the bone marrows of some hematologic malignancies (blood cancers) as treatments for patients living with cancer.
Can THLD Extend Rally? Find Out Here
Celldex Therapeutics, Inc. (NASDAQ:CLDX) is higher 7.34% and is trading at $9.19. Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company's drug candidates include CDX-110, CDX-011 and CDX-1127.
How Should Investors React To CLDX Now? Find Out Here
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)